[CLDX] QoQ Quarter Result on 31-Mar-2014 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
01-May-2014
Financial Year
2014
Quarter
31-Mar-2014 [#Q1]
Profit Trend
QoQ- -35.54%
YoY- -72.53%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Revenue 1,477 1,101 592 416 620 980 97 511.29%
PBT -31,821 -28,082 -28,274 -29,903 -22,062 -23,140 -19,016 40.81%
Tax -229 -2,260 -275 -1,586 -137 -142 -161 26.39%
NP -31,821 -28,082 -28,274 -29,903 -22,062 -23,140 -19,016 40.81%
Tax Rate - - - - - - - -
Total Cost 33,298 29,183 28,866 30,319 22,682 24,120 19,113 44.63%
Ratio Analysis
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
NP Margin -2,154.43 -2,550.59 -4,776.01 -7,188.22 -3,558.39 -2,361.22 -19,604.12 -76.96%
Per Share
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
EPS -5.33 -4.71 -4.75 -5.02 -3.71 -4.28 -3.53 31.51%
EPS Diluted -5.33 -4.71 -4.75 -5.02 -3.71 -4.28 -3.53 31.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.